Pharmacotherapy of systemic lupus erythematosus: A comparison of lupus disease activity with rituximab and sifalimumab
Crossref DOI link: https://doi.org/10.30574/wjbphs.2024.20.2.0890
Published Online: 2024-11-30
Update policy: https://doi.org/10.30574/wjbphs.ourcrossmarkpolicy
Sultan Akbar,
